학술논문

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
Document Type
Article
Source
In: Cancer Medicine. (Cancer Medicine, 1 May 2020, 9(10):3390-3399)
Subject
Language
English
ISSN
20457634